Property talk:P10245

Documentation

MedlinePlus drug identifier
identifier for a drug in the MedlinePlus database
Applicable "stated in" valueMedlinePlus (Q557919)
Data typeExternal identifier
Domainmedication (Q12140), type of chemical entity (Q113145171) or type of mixture of chemical entities (Q119892838)
Allowed valuesa6\d{5}
Examplerac-salbutamol (Q410358)a607004
levocetirizine (Q421091)a607056
naproxen (Q1215575)a681029
Sourcehttps://medlineplus.gov/spanish/druginfo/drug_Aa.html
https://medlineplus.gov/druginfo/drug_Aa.html
Formatter URLhttps://medlineplus.gov/druginfo/meds/$1.html
https://medlineplus.gov/spanish/druginfo/meds/$1-es.html
Related to country  United States of America (Q30) (See 762 others)
See alsoMedlinePlus ID (P604), MedlinePlus supplement identifier (P10246)
Lists
Proposal discussionProposal discussion
Current uses
Total1,528
Main statement1,52399.7% of uses
Qualifier30.2% of uses
Reference20.1% of uses
Search for values
[create Create a translatable help page (preferably in English) for this property to be included here]
Distinct values: this property likely contains a value that is different from all other items. (Help)
Exceptions are possible as rare values may exist. Exceptions can be specified using exception to constraint (P2303).
List of violations of this constraint: Database reports/Constraint violations/P10245#Unique value, SPARQL (every item), SPARQL (by value)
Single value: this property generally contains a single value. (Help)
Exceptions are possible as rare values may exist. Exceptions can be specified using exception to constraint (P2303). Known exceptions: nitroglycerin (Q162867), Diclofenac (Q244408), carmustine (Q415869), alemtuzumab (Q420164), propranolol (Q423364), tolvaptan (Q426132), (E/Z)-doxepin (Q71704041)
List of violations of this constraint: Database reports/Constraint violations/P10245#Single value, SPARQL
Format “a6\d{5}: value must be formatted using this pattern (PCRE syntax). (Help)
Exceptions are possible as rare values may exist. Exceptions can be specified using exception to constraint (P2303).
List of violations of this constraint: Database reports/Constraint violations/P10245#Format, SPARQL
Scope is as main value (Q54828448), as reference (Q54828450): the property must be used by specified way only (Help)
Exceptions are possible as rare values may exist. Exceptions can be specified using exception to constraint (P2303).
List of violations of this constraint: Database reports/Constraint violations/P10245#Scope, SPARQL
Allowed entity types are Wikibase item (Q29934200): the property may only be used on a certain entity type (Help)
Exceptions are possible as rare values may exist. Exceptions can be specified using exception to constraint (P2303).
List of violations of this constraint: Database reports/Constraint violations/P10245#Entity types
 
Chemical entities with no indication of use as a drug
Every item with MedlinePlus drug identifier (P10245) statement and instance of (P31)type of chemical entity (Q113145171) that has no has use (P366)medication (Q12140). In combination with other constraints it would allow in the future to properly move pharmacology-related statements from items about groups of isomers to items about specific isomer or to items about mixtures of isomers. (Help)
Violations query: SELECT DISTINCT ?item WHERE { ?item wdt:P10245 ?value. ?item wdt:P31 wd:Q113145171. MINUS { ?item wdt:P366 wd:Q12140 . } }
List of this constraint violations: Database reports/Complex constraint violations/P10245#Chemical entities with no indication of use as a drug
Return to "P10245" page.